Potassium-cit

Eywa Pharma Inc🇺🇸 United States

FDA Page

Effective Date: Dec 27, 2021
Approval ID: 5ccd4d38-0dcd-4bf7-96fd-a263ff468e1a
Products: 3 registered
Version: 4

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use POTASSIUM CITRATE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for POTASSIUM CITRATE EXTENDED-RELEASE TABLETS. POTASSIUM CITRATE extended- release tablets, for oral use Initial U.S. Approval: 1985

Quick Stats

Total Products3

Labelers2

Label Sections15

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.